Schowengerdt K O, Gajarski R J, Denfield S
Division of Pediatric Cardiology, Texas Children's Hospital, Houston 77030.
Tex Heart Inst J. 1993;20(4):299-303.
We present the case of a 10-year-old girl who developed visual loss progressing to blindness after orthotopic heart transplantation and an immunosuppressive regimen of cyclosporine, azathioprine, and prednisone. Headaches and visual deterioration began 2 months after transplantation, and a diagnosis of pseudotumor cerebri was made. The patient's visual loss continued despite aggressive medical and surgical therapy, which included bilateral optic nerve sheath fenestration. To our knowledge, permanent visual loss as a late sequela following pediatric heart transplantation and immunosuppressive therapy has not been reported previously in the English literature. Although the cause of visual loss after transplantation in our patient is poorly understood, we conclude that permanent visual loss, although rare, should be considered as a possible late neurologic sequela after pediatric heart transplantation.
我们报告了一名10岁女孩的病例,她在原位心脏移植及接受环孢素、硫唑嘌呤和泼尼松免疫抑制治疗后出现视力丧失并逐渐发展为失明。头痛和视力恶化在移植后2个月开始,诊断为假性脑瘤。尽管进行了积极的药物和手术治疗,包括双侧视神经鞘开窗术,患者的视力仍持续丧失。据我们所知,小儿心脏移植和免疫抑制治疗后永久性视力丧失作为晚期后遗症在英文文献中此前尚未有报道。虽然我们患者移植后视力丧失的原因尚不清楚,但我们得出结论,永久性视力丧失虽然罕见,但应被视为小儿心脏移植后可能出现的晚期神经后遗症。